Impact Biomedical settles $8.7M debt with 2.4M shares at $3.60/share

IMPACT BIOMEDICAL INC.

Debt conversion with DSS Inc. settles $8,697,142.80 of the $13,176,477.03 principal balance.
Issued 2,415,873 shares of common stock at $3.60 per share, equal to March 24 closing price.
Original promissory note principal was $12,000,000; amended September 16, 2024.
Settlement reduces outstanding debt by 66% while diluting existing shareholders by approximately 2.4M shares.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.